• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

30/05/2025 17:45

Titan Biotech Q4 net profit down 22.11% at Rs 3.77 cr

The company reported standalone net profit of Rs 3.77 crore for the quarter ended March 31, 2025 as compared to Rs 4.84 crore in the same period last year, registering a year-on-year decline of 22.11 per cent.

Net revenue of the company declined moderately by 11.90 per cent at Rs 35.17 crore in January-March quarter of this fiscal as against Rs 39.92 crore in the corresponding period last year.

During January-March quarter, operating expenses dropped by 6.82 per cent to Rs 30.60 crore from Rs 32.84 crore in year ago period.

Other Income grew by 187.50 per cent at Rs 1.38 crore versus (Mar'24 Rs 0.48 crore).

Operating Profit slipped by 35.45 per cent to Rs 4.57 crore as against Rs 7.08 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 26.73 per cent in March quarter.

Interest declined by 76.47 per cent y-o-y to Rs 0.08 crore, while Taxation decreased by 17.65 per cent at Rs 1.26 crore (Mar'24 Rs 1.53 crore).